Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Targeting vascular endothelial growth factor using retinal gene therapy

Annals of Translational Medicine(2021)10.21037/atm-20-4417Source: DataRank Database

Targeting vascular endothelial growth factor using retinal gene therapy is a research paper published in Annals of Translational Medicine (2021). On theSindex it has a DataRank of 0. It has been cited 34 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access34 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)OA: goldTopics (26)Linked Datasets (16)DataCite Reuse (16)IDs (PubMed, PMC)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Sonia Frick ORCID,Glenn Yiu ORCID,Sook Hyun Chung

Live enrichment

PubMed:34532414 PMC:PMC8421957

NIA NIH HHS

Grant: R25 AG048787

NEI NIH HHS

Grant: R21 EY031108

NEI NIH HHS

Grant: K08 EY026101

NEI NIH HHS

Grant: R01 EY032238

National Institutes of Health

Grant: 1K08EY026101-01

A nanoparticle platform for targeted delivery of therapeutic agents to retinal pigment epithelial or choroidal endothelial cells

National Institutes of Health

Grant: 1R21EY031108-01

Optogenetic Control of Oxidative Stress as a Model of Geographic Atrophy

goldLicense: cc-by-nc-nd

publisherhttps://atm.amegroups.com/article/viewFile/54173/pdf

publisherhttps://atm.amegroups.com/article/download/54173/pdf

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8421957

repositoryhttps://escholarship.org/uc/item/1m62x2rm

Europe_PMChttps://europepmc.org/articles/PMC8421957

Fields of Study

03 medical and health sciences0302 clinical medicine

Keywords

Gene therapyNeovascularizationAngiogenesisVascular endothelial growth factor (VEGF)Neovascular Age-related Macular Degeneration (Namd)Biomedical and clinical sciencesMedical Biotechnology610Bioengineeringneovascular age-related macular degenerationNeurodegenerativeEyeMacular Degeneration615GeneticsEye Disease and Disorders of VisionOphthalmology and Optometry5.2 Cellular and gene therapiesvascular endothelial growth factorNeurosciencesHealth sciences5.1 PharmaceuticalsReview Article on Novel Tools and Therapies for Ocular RegenerationBiotechnology

Sustainable Development Goals

SDG 3: 3. Good health

Additional file 1 of Aberrant lncRNA expression in patients with proliferative diabetic retinopathy: preliminary results from a single-center observational study

10.6084/m9.figshare.22625237.v1figshare

Additional file 1 of Aberrant lncRNA expression in patients with proliferative diabetic retinopathy: preliminary results from a single-center observational study

10.6084/m9.figshare.22625237figshare

Additional file 2 of Aberrant lncRNA expression in patients with proliferative diabetic retinopathy: preliminary results from a single-center observational study

10.6084/m9.figshare.22625240.v1figshare

Additional file 2 of Aberrant lncRNA expression in patients with proliferative diabetic retinopathy: preliminary results from a single-center observational study

10.6084/m9.figshare.22625240figshare

Additional file 3 of Aberrant lncRNA expression in patients with proliferative diabetic retinopathy: preliminary results from a single-center observational study

10.6084/m9.figshare.22625243.v1figshare

Additional file 3 of Aberrant lncRNA expression in patients with proliferative diabetic retinopathy: preliminary results from a single-center observational study

10.6084/m9.figshare.22625243figshare

Additional file 4 of Aberrant lncRNA expression in patients with proliferative diabetic retinopathy: preliminary results from a single-center observational study

10.6084/m9.figshare.22625246.v1figshare

Additional file 4 of Aberrant lncRNA expression in patients with proliferative diabetic retinopathy: preliminary results from a single-center observational study

10.6084/m9.figshare.22625246figshare

Additional file 5 of Aberrant lncRNA expression in patients with proliferative diabetic retinopathy: preliminary results from a single-center observational study

10.6084/m9.figshare.22625249.v1figshare

Additional file 5 of Aberrant lncRNA expression in patients with proliferative diabetic retinopathy: preliminary results from a single-center observational study

10.6084/m9.figshare.22625249figshare

Additional file 6 of Aberrant lncRNA expression in patients with proliferative diabetic retinopathy: preliminary results from a single-center observational study

10.6084/m9.figshare.22625252.v1figshare

Additional file 6 of Aberrant lncRNA expression in patients with proliferative diabetic retinopathy: preliminary results from a single-center observational study

10.6084/m9.figshare.22625252figshare

Additional file 7 of Aberrant lncRNA expression in patients with proliferative diabetic retinopathy: preliminary results from a single-center observational study

10.6084/m9.figshare.22625255.v1figshare

Additional file 7 of Aberrant lncRNA expression in patients with proliferative diabetic retinopathy: preliminary results from a single-center observational study

10.6084/m9.figshare.22625255figshare

Additional file 8 of Aberrant lncRNA expression in patients with proliferative diabetic retinopathy: preliminary results from a single-center observational study

10.6084/m9.figshare.22625258.v1figshare

Additional file 8 of Aberrant lncRNA expression in patients with proliferative diabetic retinopathy: preliminary results from a single-center observational study

10.6084/m9.figshare.22625258figshare